EUVIMEDEUVIMED entdecken
Open Access

Optimizing Polycythemia Vera Management Through a Collaborative Care Model Between Leukemia Oncologists and an Integrated Specialty Pharmacy

Umesh Yogarajah, Thuy Tran, Erin Cichonski, Benson Meek, John Bentz, Nicole Cowgill, Allison Karabinos, Justin Arnall

Journal of the Advanced Practitioner in Oncology · 26.06.2026 · 17 (7)

DOI: 10.6004/jadpro.2026.17.7.22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Advanced Practitioner in Oncology, online erschienen am 26.06.2026. Verfasst von Umesh Yogarajah und 7 weiteren Autor:innen. Beteiligte Einrichtung: From Roswell Park Comprehensive Cancer Center, Buffalo, New York. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycythemia vera (PV) is a chronic myeloproliferative neoplasm that requires long-term hematologic control and symptom monitoring. Despite advanced therapies and treatment guidelines, real-world adherence to therapeutic goals and routine symptom assessment remains inconsistent, particularly outside the academic setting. To optimize care, a pharmacist-led clinical support program was implemented at Levine Cancer Institute, a large regional hematologic malignancy center, in collaboration with the integrated institutional Atrium Health Specialty Pharmacy Service (SPS). This program aimed to standardize PV care system-wide by improving hematocrit (Hct) control and supporting symptom burden assessment via Myeloproliferative Neoplasm Symptom Assessment Form (MPN-10) scores. Through diagnosis code screening and identification of patients with Hct ≥ 45%, the SPS pharmacist team provided clinical reviews, pharmacotherapy recommendations, financial access support, and coordinated care, including dispensing medication and providing medication education. Interim analysis demonstrated improved identification of opportunities for optimization, with sustained provider engagement. This model highlights the opportunity for advanced practitioners, including pharmacists, to improve disease control and quality of life for patients with PV.

Autor:innen und Institutionen

  • From Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Atrium Health Specialty Pharmacy Service, Charlotte, North Carolina.
  • Atrium Health Levine Cancer Institute, Charlotte, North Carolina.

Zitieren

APA

Yogarajah, U., Tran, T., Cichonski, E., Meek, B., Bentz, J., Cowgill, N., Karabinos, A., & Arnall, J. (2026). Optimizing Polycythemia Vera Management Through a Collaborative Care Model Between Leukemia Oncologists and an Integrated Specialty Pharmacy. Journal of the Advanced Practitioner in Oncology, 17(7). https://doi.org/10.6004/jadpro.2026.17.7.22

Vancouver

Yogarajah U, Tran T, Cichonski E, Meek B, Bentz J, Cowgill N, et al. Optimizing Polycythemia Vera Management Through a Collaborative Care Model Between Leukemia Oncologists and an Integrated Specialty Pharmacy. Journal of the Advanced Practitioner in Oncology. 2026;17(7). doi:10.6004/jadpro.2026.17.7.22

BibTeX
@article{Yogarajah2026,
  author = {Yogarajah, Umesh and Tran, Thuy and Cichonski, Erin and Meek, Benson and Bentz, John and Cowgill, Nicole and Karabinos, Allison and Arnall, Justin},
  title = {Optimizing Polycythemia Vera Management Through a Collaborative Care Model Between Leukemia Oncologists and an Integrated Specialty Pharmacy},
  journal = {Journal of the Advanced Practitioner in Oncology},
  year = {2026},
  volume = {17},
  number = {7},
  doi = {10.6004/jadpro.2026.17.7.22}
}
Kostenlos starten →